The biological response modifiers (BRM) program of the National Cancer Institute

Survival Experience of 195 Patients with Hairy Cell Leukemia Treated in a Multi-Institutional Study with Interferon-Alfa 2B.

Leukemia & lymphoma·2016

Low Dose Interferon Alfa-2B for the Induction of Remission of Hairy Cell Leukemia: A Multi-institutional Study of 49 Patients.

Leukemia & lymphoma·2016

Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age.

Blood·2000

Updated analysis of an outpatient chemoimmunotherapy regimen for treating metastatic melanoma.

The cancer journal from Scientific American·1998

Interleukin-2 therapy after bone marrow or stem cell transplantation for hematologic malignancies.

The cancer journal from Scientific American·1998

Metastatic renal cell carcinoma: long-term survival after therapy with high-dose continuous-infusion interleukin-2.

The cancer journal from Scientific American·1998

From drug response to resistance evolution: Leveraging 3D cancer models for functional precision oncology.

Cancer treatment reviews·2026

Bispecific antibodies in lung cancer: From molecular engineering to clinical breakthroughs and translational challenges.

Cancer treatment reviews·2026

MTAP loss in non-small-cell lung Cancer and beyond: Therapeutic targeting of the MAT2A-PRMT5 axis.

Cancer treatment reviews·2026

Glioblastoma and resistance to radiotherapy: role of cancer stem cells subpopulations, hypoxia and therapeutic strategies.

Cancer treatment reviews·2026

Vinorelbine and low-dose cyclophosphamide as maintenance therapy in the treatment of Ewing sarcoma rationale for the international INTER-EWING-1 trial for Ewing sarcoma patients.

Cancer treatment reviews·2026

Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study.

Cancer treatment reviews·2026

Ser715 Phosphorylation Induces β-Hairpin Unfolding and Destabilization of FOXM1 Autoinhibition.

Journal of chemical information and modeling·2026

The mRNA-Based Therapeutic Vaccine NTX250 Induces Potent Antitumor Immunity in HPV-Driven Cancers.

Cancer research·2026

Alternative tobacco and nicotine products during anticancer therapy: a systematic review of mechanistic toxicology evidence, treatment-resistance signals, and potential hazards.

Toxicology mechanisms and methods·2026

Optimization of Affibody Affinity to Improve Distribution in Tumor Models.

Biomacromolecules·2026

Designing Single-Molecule Nanofiber Therapeutics for Breast Cancer and Biofilm Suppression.

Biomacromolecules·2026

Stimuli-Responsive DNA Tetrahedral Lysosome-Targeting Chimeras for Enhanced HER2 Protein Degradation.

Biomacromolecules·2026

Related Experiment Videos

The biological response modifiers (BRM) program of the National Cancer Institute

Related Concept Videos

Survival Experience of 195 Patients with Hairy Cell Leukemia Treated in a Multi-Institutional Study with Interferon-Alfa 2B.

Low Dose Interferon Alfa-2B for the Induction of Remission of Hairy Cell Leukemia: A Multi-institutional Study of 49 Patients.

Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age.

Updated analysis of an outpatient chemoimmunotherapy regimen for treating metastatic melanoma.

Interleukin-2 therapy after bone marrow or stem cell transplantation for hematologic malignancies.

Metastatic renal cell carcinoma: long-term survival after therapy with high-dose continuous-infusion interleukin-2.

From drug response to resistance evolution: Leveraging 3D cancer models for functional precision oncology.

Bispecific antibodies in lung cancer: From molecular engineering to clinical breakthroughs and translational challenges.

MTAP loss in non-small-cell lung Cancer and beyond: Therapeutic targeting of the MAT2A-PRMT5 axis.

Glioblastoma and resistance to radiotherapy: role of cancer stem cells subpopulations, hypoxia and therapeutic strategies.

Vinorelbine and low-dose cyclophosphamide as maintenance therapy in the treatment of Ewing sarcoma rationale for the international INTER-EWING-1 trial for Ewing sarcoma patients.

Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study.

Ser715 Phosphorylation Induces β-Hairpin Unfolding and Destabilization of FOXM1 Autoinhibition.

The mRNA-Based Therapeutic Vaccine NTX250 Induces Potent Antitumor Immunity in HPV-Driven Cancers.

Alternative tobacco and nicotine products during anticancer therapy: a systematic review of mechanistic toxicology evidence, treatment-resistance signals, and potential hazards.

Optimization of Affibody Affinity to Improve Distribution in Tumor Models.

Designing Single-Molecule Nanofiber Therapeutics for Breast Cancer and Biofilm Suppression.

Stimuli-Responsive DNA Tetrahedral Lysosome-Targeting Chimeras for Enhanced HER2 Protein Degradation.

Related Experiment Videos

The biological response modifiers (BRM) program of the National Cancer Institute

Related Concept Videos

Related Articles